CoChat

Diabetes, hypertension, and cardiovascular derangements: Pathophysiology and management

El-Atat, Fadi, McFarlane, Samy I., Sowers, James R. · 2004 · Current Hypertension Reports

The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.

Abstract

Hypertension frequently coexists with diabetes mellitus, occurring twice as frequently in diabetic as in nondiabetic persons. It accounts for up to 75% of added cardiovascular disease (CVD) risk in people with diabetes, contributing significantly to the overall morbidity and mortality in this high-risk population. Patients with hypertension are two times more prone to have diabetes than are normotensive persons. Hypertension substantially increases the risk for coronary heart disease (CHD), stroke, retinopathy, and nephropathy. In patients with type 2 diabetes, hypertension usually clusters with the other components of the cardiometabolic syndrome, such as microalbuminuria, central obesity, insulin resistance, dyslipidemia, hypercoagulation, increased inflammation, and left ventricular hypertrophy (LVH). In type 1 diabetes, hypertension often occurs subsequent to the development of diabetic nephropathy. Hypertension in people with diabetes is characterized by volume expansion, increased salt sensitivity, isolated systolic blood pressure (BP) elevation, loss of the nocturnal dipping of BP and pulse, and increased propensity toward orthostatic hypotension and albuminuria. Among the treatment strategies tested in hypertensive diabetic persons, low-density lipoprotein (LDL)-cholesterol lowering to less than 100 mg/dL and aggressive BP control to less than 130/80 mm Hg have proven effective in CVD risk reduction. The combination of two or more drugs is usually necessary to achieve the target BP.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11906-004-0072-y

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 86 references

Cited by

See all 121

Metadata

Authors
El-Atat, F., McFarlane, S. I., & Sowers, J. R.
Affiliations
University of Missouri (US)
Venue
Current Hypertension Reports
Published
2004-05
Volume
6
Issue
3
Pages
215-223
ISSN
  • 1522-6417 (ISSN-L)
  • 1534-3111
OpenAlex
W2059318749
Cited by
121
References
86
Citations by year
2026: 2 · 2025: 1 · 2024: 5 · 2023: 4 · 2022: 5 · 2021: 4 · 2020: 3 · 2019: 5 · 2018: 4 · 2017: 2 · 2016: 6 · 2015: 3 · 2014: 6 · 2013: 2 · 2012: 7
FWCI
2.00
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Current Hypertension Reports (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Keywords
hypertension, diabetes mellitus, cardiovascular risk, cardiometabolic syndrome, type 2 diabetes, type 1 diabetes, diabetic nephropathy, coronary artery disease, stroke, retinopathy, albuminuria, left ventricular hypertrophy, salt sensitivity, nocturnal blood pressure dipping, orthostatic hypotension, LDL cholesterol lowering, blood pressure control, combination antihypertensive therapy
MeSH terms
Adrenergic beta-Antagonists, Angiotensin-Converting Enzyme Inhibitors, Blood Pressure, Calcium Channel Blockers, Cardiovascular Diseases, Diabetes Mellitus, Heart Rate, Humans, Hyperinsulinism, Hypertension, Hypoglycemic Agents, Insulin Resistance, Receptors, Angiotensin, Angiotensin Receptor Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diabetes, hypertension, and cardiovascular derangements: Pathophysiology and management. https://app.cochat.ai/papers/10.1007/s11906-004-0072-y
The paper
El-Atat, F., McFarlane, S. I., & Sowers, J. R. (2004). Diabetes, hypertension, and cardiovascular derangements: Pathophysiology and management. Current Hypertension Reports. https://doi.org/10.1007/s11906-004-0072-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.